ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Hilge
|
54 |
22K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
22K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Hilge
|
54 |
22K |
28 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
22K
|
28
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
20 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
20
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hilge
|
743 |
339K |
8 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
743
|
339K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hilge
|
743 |
339K |
1 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
743
|
339K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
Hilge
|
27 |
15K |
39 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
27
|
15K
|
39
|
|
ASX - By Stock
|
IMM |
Re:
Ann: FDA supportive of Efti registrational trial in lung cancer
|
|
Hilge
|
11 |
8.7K |
23 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
11
|
8.7K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
18 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Initiation of Ph 2/3 Trial for Metastatic Breast Cancer
|
|
Hilge
|
9 |
6.1K |
12 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
9
|
6.1K
|
12
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Two New Discoveries at Minyari Dome
|
|
Hilge
|
47 |
26K |
5 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
47
|
26K
|
5
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Resource Drilling Increases Minyari Deposit Confidence
|
|
Hilge
|
15 |
7.9K |
2 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
15
|
7.9K
|
2
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Antipa Regains 100% Interest in High Priority Targets
|
|
Hilge
|
43 |
17K |
5 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
43
|
17K
|
5
|
|
ASX - By Stock
|
AZY |
Re:
Newcrest take over
|
|
Hilge
|
37 |
16K |
0 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
37
|
16K
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Newcrest take over
|
|
Hilge
|
37 |
16K |
3 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
37
|
16K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
20 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
20
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Update on MBC trial design following successful FDA meeting
|
|
Hilge
|
22 |
12K |
11 |
26/12/22 |
26/12/22 |
ASX - By Stock
|
22
|
12K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Hilge
|
382 |
194K |
16 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
382
|
194K
|
16
|
|
ASX - By Stock
|
AZY |
Re:
Recent Gold M&A in Australia - Big Premiums on Acquisitions
|
|
Hilge
|
311 |
149K |
0 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
311
|
149K
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Minyari Drilling Identifies Resource Growth Opportunities
|
|
Hilge
|
38 |
25K |
1 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
38
|
25K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Minyari Drilling Identifies Resource Growth Opportunities
|
|
Hilge
|
38 |
25K |
0 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
38
|
25K
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Minyari Drilling Identifies Resource Growth Opportunities
|
|
Hilge
|
38 |
25K |
0 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
38
|
25K
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Ann: German Gold Show Conference Presentation
|
|
Hilge
|
35 |
22K |
11 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
35
|
22K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters 2nd collaboration with Pfizer and Merck KGaA
|
|
Hilge
|
18 |
9.8K |
28 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
18
|
9.8K
|
28
|
|
ASX - By Stock
|
AZY |
Re:
Telfer the Elephant in the Room
|
|
Hilge
|
95 |
50K |
4 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
95
|
50K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
Hilge
|
16 |
8.0K |
18 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
16
|
8.0K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 data presented at SITC for Efti in 1st line NSCLC
|
|
Hilge
|
11 |
7.3K |
10 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
11
|
7.3K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
16 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
9 |
05/11/22 |
05/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
15 |
05/11/22 |
05/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
15
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Multiple Drilling Programmes in Progress at Growth Projects
|
|
Hilge
|
8 |
5.1K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
8
|
5.1K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Change of Director's Interest Notice (x3)
|
|
Hilge
|
2 |
1.4K |
5 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
2
|
1.4K
|
5
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Completion of Share Purchase Plan
|
|
Hilge
|
10 |
5.7K |
1 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
10
|
5.7K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Completion of Share Purchase Plan
|
|
Hilge
|
10 |
5.7K |
2 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Completion of Share Purchase Plan
|
|
Hilge
|
10 |
5.7K |
5 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
10
|
5.7K
|
5
|
|
ASX - By Stock
|
AZY |
Re:
Recent Gold M&A in Australia - Big Premiums on Acquisitions
|
|
Hilge
|
311 |
149K |
1 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
311
|
149K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Recent Gold M&A in Australia - Big Premiums on Acquisitions
|
|
Hilge
|
311 |
149K |
2 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
311
|
149K
|
2
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Settlement of $9M Placement Funds
|
|
Hilge
|
8 |
4.7K |
2 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
8
|
4.7K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Clinical Development Update for Eftilagimod Alpha
|
|
Hilge
|
12 |
5.8K |
11 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
12
|
5.8K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
|
|
Hilge
|
35 |
11K |
4 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
35
|
11K
|
4
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Successful $9M Placement and Launch of $3M SPP
|
|
Hilge
|
68 |
26K |
1 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
68
|
26K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Successful $9M Placement and Launch of $3M SPP
|
|
Hilge
|
68 |
26K |
4 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
68
|
26K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
4 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
5 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Hilge
|
2.7K |
1.1M |
0 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Strong Minyari Dome Scoping Study Outcomes
|
|
Hilge
|
80 |
38K |
0 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
80
|
38K
|
0
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Pause in Trading
|
|
Hilge
|
73 |
29K |
2 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
73
|
29K
|
2
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Strong Minyari Dome Scoping Study Outcomes
|
|
Hilge
|
80 |
38K |
4 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
80
|
38K
|
4
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Pause in Trading
|
|
Hilge
|
73 |
29K |
1 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
73
|
29K
|
1
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Pause in Trading
|
|
Hilge
|
73 |
29K |
3 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
73
|
29K
|
3
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Pause in Trading
|
|
Hilge
|
73 |
29K |
6 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
73
|
29K
|
6
|
|